Cartesian Therapeutics, Inc. RNAC announced positive top-line results from its mid-stage study evaluating lead candidate Descartes-08 in patients with generalized myasthenia gravis (MG), an autoimmune ...
July 2 (Reuters) - Cartesian Therapeutics (RNAC.O), opens new tab said on Tuesday that its experimental therapy helped reduce symptoms of a rare, immune-related disorder, meeting the main goal in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback